Etodolac
Product Images NDC 21695-049

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 21695-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Db60911a 2bb1 4e8c Baf0 7cf281bf5778 01)

FDA Label Image

Etodolac 300mg (Db60911a 2bb1 4e8c Baf0 7cf281bf5778 02)

Etodolac 300mg (Db60911a 2bb1 4e8c Baf0 7cf281bf5778 02)
Peel Peel is a medication containing Etodolac, USP available in the form of opaque, dark red body and cap, size #0 hard gelatin capsules with a radial imprint using gray ink, N 397/ 300 on the cap portion and three narrow bands on the body portion. Each capsule contains 300mg of Etodolac, USP. Peel Peel is packaged by Physician Partner and manufactured by Novopharm Limited in Toronto, Canada. The product identifier for Peel Peel is PE004942CA. It is recommended to keep the medication out of the reach of children and store it at a controlled room temperature of 15°-C (59°-86°F).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.